Polina Kalmanovich, PharmD, holds a prominent position as Head of Global Program Management at Sarepta Therapeutics, where responsibilities include overseeing global program initiatives. Kalmanovich has previously served as Executive Director of R&D Business Strategy and Operations and Senior Director of Gene Therapy and Regulatory Affairs at the same company. Additional experience includes co-owning Laguna Family Dentistry and serving as Senior Director of Regulatory Affairs and Quality Assurance at Novus Therapeutics, Inc. Prior roles also encompass positions at Allergan as Director of Global Regulatory Affairs and Associate Director of Regulatory Affairs, as well as Director of Regulatory Affairs at Chase Pharmaceuticals. Kalmanovich earned a Master of Science in Regulatory Science from the University of Southern California and completed an executive education program at Harvard Business School in late 2021.